- Home
- LYEL vs ORMP Comparison
LYEL vs ORMP Comparison
Compare LYEL & ORMP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- LYEL
- ORMP
- Stock Information
- Founded
- LYEL 2018
- ORMP 2002
- Country
- LYEL United States
- ORMP United States
- Employees
- LYEL N/A
- ORMP N/A
- Industry
- LYEL Biotechnology: Pharmaceutical Preparations
- ORMP Biotechnology: Pharmaceutical Preparations
- Sector
- LYEL Health Care
- ORMP Health Care
- Exchange
- LYEL Nasdaq
- ORMP Nasdaq
- Market Cap
- LYEL 263.9M
- ORMP 97.6M
- IPO Year
- LYEL 2021
- ORMP N/A
- Fundamental
- Price
- LYEL $0.65
- ORMP $2.41
- Analyst Decision
- LYEL Sell
- ORMP Hold
- Analyst Count
- LYEL 2
- ORMP 1
- Target Price
- LYEL $1.00
- ORMP N/A
- AVG Volume (30 Days)
- LYEL 1.3M
- ORMP 209.8K
- Earning Date
- LYEL 02-26-2025
- ORMP 01-07-2025
- Dividend Yield
- LYEL N/A
- ORMP N/A
- EPS Growth
- LYEL N/A
- ORMP N/A
- EPS
- LYEL N/A
- ORMP 0.11
- Revenue
- LYEL $63,000.00
- ORMP N/A
- Revenue This Year
- LYEL N/A
- ORMP N/A
- Revenue Next Year
- LYEL N/A
- ORMP N/A
- P/E Ratio
- LYEL N/A
- ORMP $21.93
- Revenue Growth
- LYEL N/A
- ORMP N/A
- 52 Week Low
- LYEL $0.58
- ORMP $2.00
- 52 Week High
- LYEL $3.26
- ORMP $3.67
- Technical
- Relative Strength Index (RSI)
- LYEL 34.74
- ORMP 51.12
- Support Level
- LYEL $0.60
- ORMP $2.32
- Resistance Level
- LYEL $0.71
- ORMP $2.51
- Average True Range (ATR)
- LYEL 0.06
- ORMP 0.09
- MACD
- LYEL 0.01
- ORMP -0.01
- Stochastic Oscillator
- LYEL 23.51
- ORMP 50.00
About LYEL Lyell Immunopharma Inc.
Lyell Immunopharma Inc is a clinical-stage cell therapy company. It has a pipeline of product candidates for patients with solid tumors utilizing ex vivo genetic and epigenetic T-cell reprogramming technologies. The company's product pipeline includes, LYL797, LYL119, LYL845 among others.
About ORMP Oramed Pharmaceuticals Inc.
Oramed Pharmaceuticals Inc is a pharmaceutical company that is engaged in the research and development of pharmaceutical solutions with a technology platform that allows for the oral delivery of therapeutic proteins. developed an oral dosage form intended to withstand the harsh environment of the stomach and effectively deliver active biological insulin or other proteins. Its product pipeline includes ORMD-0801, ORMD-0801, and ORMD 0901.